APELLIS PHARMACTDL (Germany) Probability of Future Stock Price Finishing Over 73.41
1JK Stock | EUR 31.22 0.02 0.06% |
APELLIS |
APELLIS PHARMACTDL Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of APELLIS PHARMACTDL for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for APELLIS PHARMACTDL 0001 can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.APELLIS PHARMACTDL had very high historical volatility over the last 90 days | |
The company reported the revenue of 113.05 M. Net Loss for the year was (460.28 M) with loss before overhead, payroll, taxes, and interest of (253.92 M). | |
APELLIS PHARMACTDL 0001 has accumulated about 599.01 M in cash with (239.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.89. | |
Over 89.0% of the company shares are owned by institutions such as pension funds |
APELLIS PHARMACTDL Technical Analysis
APELLIS PHARMACTDL's future price can be derived by breaking down and analyzing its technical indicators over time. APELLIS Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of APELLIS PHARMACTDL 0001. In general, you should focus on analyzing APELLIS Stock price patterns and their correlations with different microeconomic environments and drivers.
APELLIS PHARMACTDL Predictive Forecast Models
APELLIS PHARMACTDL's time-series forecasting models is one of many APELLIS PHARMACTDL's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary APELLIS PHARMACTDL's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about APELLIS PHARMACTDL 0001
Checking the ongoing alerts about APELLIS PHARMACTDL for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for APELLIS PHARMACTDL 0001 help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
APELLIS PHARMACTDL had very high historical volatility over the last 90 days | |
The company reported the revenue of 113.05 M. Net Loss for the year was (460.28 M) with loss before overhead, payroll, taxes, and interest of (253.92 M). | |
APELLIS PHARMACTDL 0001 has accumulated about 599.01 M in cash with (239.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.89. | |
Over 89.0% of the company shares are owned by institutions such as pension funds |
Other Information on Investing in APELLIS Stock
APELLIS PHARMACTDL financial ratios help investors to determine whether APELLIS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in APELLIS with respect to the benefits of owning APELLIS PHARMACTDL security.